Betamethasone cream 15g

$16.00

Betamethasone cream 15g

Reduce the inflammatory manifestations of dermatoses that are sensitive to GCS therapy

Free international shipping

Description

Betamethasone cream 15g

Pharmacotherapeutic group: Corticosteroids for dermatological use. ATX code D07A C01.
Composition:
active substance: betamethasone;
1 g of cream contains betamethasone dipropionate * 0.64 mg Excipients: methylparaben (methyl parahydroxybenzoate) (E 218) 2 mg imidourea 5 mg propylene glycol; glycerin mineral oil; white soft paraffin; dimethicone; cetostearyl alcohol; polyethylene glycol (macrogol) cetostearyl ether; sodium dihydrogen phosphate monohydrate, diluted phosphoric acid; purified water. * – betamethasone dipropionate, in terms of 100% substance.
 
Indications:
To reduce the inflammatory manifestations of dermatoses that are sensitive to GCS therapy, such as eczema and dermatitis of all types (including atopic eczema and photodermatitis), lichen planus, prurigo nodosa, discoid lupus erythematosus, necrobiosis lipoid, pretibial myxedema and erythroderma. It can also be effective in the treatment of scalp psoriasis, plaque psoriasis on the skin of the upper and lower extremities, excluding the common plaque psoriasis.
Contraindications:
Betamethasone is contraindicated for patients with allergic reactions to any of the components of the drug. Drug is contraindicated in the following cases: viral infections, including post-vaccination reactions and chickenpox; viral skin infections (eg, herpes simplex, shingles, chickenpox); rosacea; rosacea-like (perioral) dermatitis – bacterial dermatoses, including tuberculosis and skin syphilis; fungal diseases; ophthalmic diseases (Betamethasone is not intended for ophthalmic use). It is not recommended to use Betamethasone cream under occlusive dressings (gypsum, etc.). Special care should be taken when applying drug to the face. Do not allow the drug to come into contact with eyes or mucous membranes. Long-term treatment and / or application on a large surface of the skin should be avoided, since absorption of the active substance is possible. You should not use the cream in the first trimester of pregnancy (see section “Use during pregnancy or lactation”).
Method of administration and dosage:
Betamethasone cream should be applied in a thin layer to the affected skin 1-2 times a day, depending on the severity. Apply a sufficient amount of Betamethasone Cream in a thin layer to completely cover the affected skin areas and rub gently into the skin. If the condition improves, the frequency of applications can be reduced. Avoid prolonged use of Betamethasone cream or applying the cream to large areas (more than 20% of the body surface). This also applies to the treatment of more than 10% of the body surface for more than 1 week. After improving the clinical picture, the use of a weak GCS is often recommended. It is recommended to carefully monitor the development of signs and symptoms of systemic drug action. The method of application should be adapted to the skin type and stage of the disease. Do not use in occlusive dressings, as side effects of the drug may increase.
Application features:
It is not intended for ophthalmic use.
Systemic absorption of topical corticosteroids tends to increase with increasing corticosteroid dosage, duration of treatment, and body surface area treated. Therefore, corticosteroids with high activity in large areas of the skin should be used under careful and periodic monitoring, since they can cause depression of the hypothalamic-pituitary-adrenal system (HPA). If depression develops, the drug should be canceled, the frequency of application should be reduced or the patient should be switched to a weaker corticosteroid drug.
The function of the HPA is usually restored when the drug is discontinued. In some cases, withdrawal symptoms may develop, which require the addition of a systemic corticosteroid. It is generally well tolerated. However, treatment should be discontinued if irritation or hypersensitivity occurs. Betamethasone cream contains cetostearyl alcohol. Cetostearyl alcohol can cause local, localized skin irritations (eg, contact dermatitis).
If skin irritation occurs or signs of hypersensitivity appear in connection with the use of the drug, treatment should be discontinued and the patient should be selected for adequate therapy. In the presence of infection, antifungal or antibacterial agents should be prescribed, respectively. If the desired effect does not occur quickly, the use of corticosteroids should be discontinued until signs of infection are eliminated.
Shelf life:
4 years.
Storage conditions:
Store in original packaging at a temperature not exceeding 25 ° C. Do not freeze. Keep out of the reach of children.
Produced in Ukraine